News And Announcements
Faron's Traumakine approved as investigational new drug
Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that the US Food and Drug Administration (FDA) has approved the investigational new drug (IND) application for ‘Traumakine’ - its wholly-owned product for the treatment of acute respiratory distress syndrome (ARDS), which is part of the regulatory process towards Biologics License Application (BLA) submission.
Surge in pulp prices cripples James Cropper
Advanced materials and paper products group James Cropper issued a trading update on Wednesday, as it faced further headwinds in the rising cost of pulp.
UK CPT offloads shopping centres to Shropshire Council
Guernsey-based investment firm UK Commercial Property Trust has completed the sale of its three retail centres in Shrewsbury town centre to Shropshire Council for roughly £51m, representing a small premium to book value.
Petrofac CEO handed supportive judgement over Italian insider trading charge
Petrofac's chief executive Ayman Asfari has been cleared by the UK High Court of insider trading in Italy, with the Italian authorities found to have not followed due process in allowing him to defend himself.
US chipmaker Qualcomm fined €1bn by Brussels for collusion with Apple
US chipmaker Qualcomm has been fined €997m ($1. 2bn) by the European Commission, after it was found to have illegally paid tech giant Apple billions of dollars to use its chips exclusively.
Simplified business leads to reduced loss for cloudBuy
Cloud-based e-commerce marketplace and business-to-business buyer and supplier solutions provider cloudBuy updated the market on trading on Wednesday, ahead of its full-year results expected on 16 March.
Markets help propel Time Out Group in 2017
Global media and entertainment business Time Out Group updated the market on trading for the 12 months to 31 December on Wednesday, reporting that revenue and adjusted EBITDA were anticipated to be in line with its expectations for the full year.
Carillion executives, KPMG face parliamentary inquiry over collapse
Senior executives from collapsed government contractor Carillion will be grilled by MPs on February 6 as part of a joint parliamentary inquiry into the firm's demise.
Shire gets FDA approval for technology transfer of Cinryze drug
Shire has received approval from the US Food and Drug Administration for the technology transfer of its Cinryze drug product manufacturing process to its site in Vienna, Austria.
Tri-Star puts an extra $2.8m into Oman Antimony Roaster project
Tri-Star Resources announced on Wednesday that it has invested a further $2. 8m (£2. 05m ) via additional mezzanine loan to Strategic & Precious Metals Processing (SPMP), to assist in further development of the Oman Antimony Roaster (OAR) project.
PPHE buys out partner at Hoxton hotel development site
Full-service upscale and lifestyle hotel company PPHE Hotel Group announced on Wednesday that one of its wholly-owned subsidiaries has exchanged contracts to buy from its joint venture partner its 50% interest in its joint venture company, Aspirations, for a consideration of £35m, subject to working capital adjustments to be made on completion.
ImmuPharma raises £10m following investor demans
Specialist drug discovery and development company ImmuPharma announced on Wednesday that, in response to institutional demand, it has completed a fundraise totalling £10m before expenses via a placing of 6,944,445 new ordinary shares at a price of 144p per share, with new and existing investors.
Hotel Chocolat posts 15% jump in revenue
AIM-listed British chocolatier Hotel Chocolat posted a jump in revenue on Wednesday.
WH Smith sales slip over Christmas period as high street struggles
Sales at retailer WH Smith fell over the Christmas period, mostly on the back of a weaker performance from its high street stores.
Purplebricks to launch in New York in second quarter
Online estate agent Purplebricks has announced plans to launch into the New York market in the second quarter of this year.
Fever-Tree fizzes higher on upbeat full-year outlook
Fever-Tree fizzed higher on Wednesday as the posh tonic maker said the outcome for the full-year will be "comfortably ahead" of market expectations on the back of "very strong" growth.
Countrywide CEO Alison Platt resigns less than a week after profit warning
Countrywide said on Wednesday that chief executive officer Alison Platt has resigned, less than a week after the company's shares tumbled on the back of a profit warning.
McCarthy & Stone 'resilient' amid ground rent uncertainty
Retirement housebuilder McCarthy & Stone reported a continuation of ‘resilient’ trading in an update on Wednesday, as investors gathered in London for the group’s annual general meeting.
JD Wetherspoon dishes out another strong dose of sales and Brexit rhetoric
Pub operator JD Wetherspoon reported another strong quarter of growth and chairman Tim Martin served up another robust dose of rhetoric on the subject of food and drink prices post-Brexit.
Polymetal shines as gold production lifts revenue
Strong fourth quarter gold production helped Russian miner Polymetal post a 12% rise in revenue to $586m.